Sen. Grassley Presses HHS On Ethics Of FDA-Approved Blood Substitute Study
This article was originally published in The Pink Sheet Daily
Executive Summary
Grassley wants an investigation into FDA’s approval of a protocol that allowed patients to be treated with a blood substitute even though blood was available.